Dr. Ali T. Dural, MD

Dr. Dural practices at Woodlands Endoscopy Center - HOPD in Shenandoah, Texas.

Dr. Dural's NPI, 1376543470, was assigned on July 29, 2005. Dr. Dural graduated from Ege Univ- Fac Med in 1991. Dr. Dural holds Texas license J9005.

Dr. Dural's primary practice is Woodlands Endoscopy Center - HOPD, at 111 Vision Park Blvd STE 230, Shenandoah, TX 77384.

Dr. Dural's primary practice is Woodlands Endoscopy Center - HOPD in Shenandoah, Texas. Dr. Dural is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Digestive Specialists, P.A. Dmand AI also links Dr. Dural to 4 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dural practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Dural's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Dural is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Dural's licenses on file in 2 states: Texas and Illinois.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Dural treats.

CMS data shows 1,918 Medicare services from Dr. Dural across 11 procedure codes in 2024, for 1,021 Medicare patients. Medicare paid $185,692 for them.

CMS counts 1,021 Medicare patients who saw Dr. Dural in 2024. The largest group is 65 to 74, with 596 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dural's median patient age at 64, with 52% women.

In 2024, Dr. Dural wrote 2,123 Medicare Part D claims for 613 patients. 87% of them were for generic drugs. CMS names the drug for 1,868 of them, across 34 drugs with 11 or more claims each, at $474,555 in total drug cost. In 2023, CMS named 1,618 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dural for performance year 2024, reported individually. Dr. Dural accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 221 procedures of colonoscopy by Dr. Dural, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Dural. The most frequent topics are Liver Function Tests. Dr. Dural has published most often in Dig Dis Sci. Dr. Dural's most frequent co-author is Boris Yoffe.

CMS Open Payments shows 82 general payments to Dr. Dural from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,842.

Dmand AI lists 2 awards for Dr. Dural, most recently CMS Stage 1 EHR in 2013.

Dr. Dural graduated from Ege Univ- Fac Med in 1991. Dr. Dural is a member of ACG and ASGE.

Dr. Dural is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.